Life Science

Entegris Expands Life Sciences Facilities

Entegris' Aramus critical fluid handling product line is used to produce and deliver vaccines worldwide like the COVID-19 vaccines. / Photo courtesy of Entegris, Inc.

Billerica, MA – Entegris, Inc., a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries, announced the expansion of its Life Sciences manufacturing facilities located in Billerica, Mass.; Bloomington, Minn.; and Logan, Utah.

Entegris has also started development of its Life Sciences Technology Center, located at its headquarters in Billerica. The facility will be dedicated to providing application testing, process development, and solution demonstration services for bioprocess technologies including freeze, thaw, and filtration applications.

The expansions are part of Entegris’ capital expenditures plan to invest approximately $30 million in life sciences capacity and capabilities this year, in addition to the $10 million invested in 2020. The facilities will develop and manufacture bioprocessing assemblies, such as its Aramus critical fluid handling product line currently used to produce and deliver vaccines worldwide. The company anticipates hiring nearly 200 additional employees with engineering and production experience throughout 2021 to support increased demand for its products.

The expansion of Entegris’ bioprocessing facilities comes as the pharmaceutical sector increases demand for high-purity systems designed for freezing, transporting, storing, and thawing drug substances. In addition to COVID-19 vaccines, these solutions are also applicable in the production of other treatments and therapeutics.

Take advantage of High-Profile’s current subscription rates now, by signing up for a monthly or annual subscription!

Learn More!